A new conditional mouse model for Cre-mediated restoration of Hprt1 expression during brain development
Havelaar, J. R. J.; Fuss, A.; Blaess, S.; Kolk, S. M.; Visser, J. E.
Show abstract
A central challenge in genetic neurodevelopmental disorders is determining the developmental windows, brain regions, and cell lineages that are affected by gene dysfunction, and whether the resulting pathology remains reversible. The defined genotype-phenotype relationship in Lesch-Nyhan disease (LND), a monogenic disorder caused by pathogenic variants in HPRT1 and subsequent deficiency of the purine salvage enzyme hypoxanthine-guanine phosphoribosyltransferase (HGprt), provides a well-characterized disease context for such mechanistic investigations. We present a new conditional Hprt1 mouse model carrying a loxP-flanked mCherry and transcriptional stop cassette, permitting Cre-driver-dependent analysis of spatially and temporally controlled restoration of endogenous Hprt1 expression during brain development. Hprt1 reactivation was confirmed at the genomic, transcriptional, and biochemical levels. Using the ubiquitous tamoxifen-inducible CAG-CreER driver, a single maternal tamoxifen dose at embryonic day (E)8.5 restored whole-brain Hprt1 mRNA expression and HGprt enzyme activity in E14.5 embryos to 72.4% and 13.4% of wild-type levels, respectively. Postnatal exposure through lactation during maternal treatment from postnatal day (P)0 to P4 yielded whole-brain HGprt activity equivalent to 28.3% of the WT level at P17. However, ligand-independent CAG-CreER activity and treatment-associated reproductive and developmental complications precluded extended longitudinal rescue studies with this Cre-driver. Developmentally regulated Wnt1-Cre2 activity, from E8 onwards, provided an alternative approach that permitted analysis through P60. Although the Wnt1 lineage constitutes only a fraction of the developing brain, Cre-dependent reactivation produced detectable HGprt activity in the forebrain, midbrain, and hindbrain. RNA fluorescent in situ hybridization (FISH) detected spatially distributed Hprt1 reactivation in the midbrain and prefrontal cortex at E14.5 and across multiple midbrain, cortical, and subcortical regions at P60. These findings establish the conditional Hprt1tm1.1(LoxP-mCherry-Stop-LoxP)Vsr mouse as a model for investigating when and where Hprt1 restoration could rescue abnormal brain development, while demonstrating that Cre-driver properties determine experimental specificity and longitudinal feasibility. Beyond LND, this conditional reactivation strategy provides an approach for defining developmental windows of reversibility and lineage-specific requirements for gene restoration in monogenic neurodevelopmental disorders.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Benefits of global mutant huntingtin lowering diminish over time in a Huntington's disease mouse model 92%
- GABAergic interneurons contribute to the fatal seizure phenotype of CLN2 disease mice 91%
- Purkinje Cell-specific Deficiency in SEL1L-HRD1 Endoplasmic Reticulum-Associated Degradation Causes Progressive Cerebellar Ataxia in Mice 91%
Similar papers in this journal
- Gene therapy targeting the blood-brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency 92%
- Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome 91%
- A CAG repeat threshold for therapeutics targeting somatic instability in Huntington's disease 91%
Similar papers in this journal
- Endosomal trafficking defects alter neural progenitor proliferation and cause microcephaly 93%
- Reducing methylation of histone 3.3 lysine 4 in the medial ganglionic eminence and hypothalamus recapitulates neurodevelopmental disorder phenotypes 93%
- Early differential impact of MeCP2 mutations on functional networks in Rett syndrome patient-derived human cerebral organoids 93%
Similar papers in this journal
- MCOLN1 gene-replacement therapy corrects neurologic dysfunction in the mouse model of mucolipidosis IV. 93%
- Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat 92%
- Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro 91%
Similar papers in this journal
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43. 92%
- Novel Mouse Model of Alternating Hemiplegia of Childhood Exhibits Prominent Motor and Seizure Phenotypes 91%
- Epilepsy and neurobehavioral abnormalities in mice with a KCNB1 pathogenic variant that alters conducting and non-conducting functions of KV2.1 91%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.